Enter your email address:

Delivered by FeedBurner

Aurobindo Pharma gets USFDA nod for generic antidepressant tablets

The company has received the final approval from the US Food and Drug
Administration (USFDA) to manufacture and market Fluoxetine tablets in
the strengths of 10 mg and 20 mg, Aurobindo Pharma said in a filing to
BSE. The tablets are generic version of Eli Lilly's Prozac tablets, it
added. The product will be launched in April 2020.



Post a Comment